Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 83INDUSTRY 33NIH 10NETWORK 2FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Rare Diseases 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Neoplasms by Site 1Neoplasm Metastasis 1Myasthenia Gravis 1Mental Disorders 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Head and Neck Neoplasms 1Early Stage Lung Cancer (I and II) 1Condylomata Acuminata 1Colonic Polyps 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Bronchogenic 1Cachexia 1Breast Neoplasms 1Anxiety Disorders 1Adenomatous Polyposis Coli 1

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × FED × Liver Neoplasms × Clear all
NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

James A. Haley Veterans Administration Hospital

Phase 1 Terminated
30 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡